Drug Search Results
More Filters [+]

Emivirine

Alternative Names: emivirine
Latest Update: 2008-08-14
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: NNRT Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Gilead Sciences
Company Location: FOSTER CITY CA 94404
Company CEO: Daniel P. O’Day
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Emivirine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: HIV Infections

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

292B

P2

Completed

HIV Infections

None

Recent News Events

Date

Type

Title